Rule would allow generic drugs manufacturers to change labels without FDA approval.
The FDA needs to complete its approval process for generic versions of biologic drugs.
Rep. Henry Waxman said new rules would ease concerns on potential dangers of generic drugs.
New draft rule would let generic drug manufacturers speed up changes to their safety labels.
Biologics treat some of the most devastating diseases around and no one should be denied access to...
Senator wants drugmakers to pick up the tab of higher costs to Medicaid programs.
Two lawmakers called on the administration to prevent the increasing costs of generic drugs.
The Federal Register isn’t being published on Monday, since the federal government is formally...
Yesterday the Health, Education, Labor and Pensions (HELP) Committee approved legislation yesterday...